Arkolith/Insider Trading/MACK/Form 4

Crocker Gary L

See Remarks, DirectorMERRIMACK PHARMACEUTICALS INC (MACK) · full profile →Form 4 · filed May 19, 2022
Net Buying
Open-Market Buys
$27K
Open-Market Sells
$0
Net Open-Market Flow
$27K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 18, 2022Buy(P)5K$5.08$25K123K
May 17, 2022Buy(P)225$5.10$1K118K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-018778) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML